Binding and signalling properties of a growth hormone enhancing monoclonal antibody

• Published in: Molecular and cellular biochemistry Vol. 198; no. 1-2; pp. 61 - 67
• Main Authors: Beattie, J, Bramani, S, Secchi, C, Mockridge, J
• Format: Journal Article
• Language: English
• Published: Netherlands Springer Nature B.V 01-08-1999
• Subjects: 3T3 Cells; Adipocytes - cytology; Adipocytes - metabolism; Animals; Antibodies, Monoclonal - metabolism; Biosensors; Cattle; Epitope Mapping; Growth Hormone - chemistry; Growth Hormone - immunology; Growth hormones; Janus Kinase 2; Mice; Phosphorylation; Protein Conformation; Protein-Tyrosine Kinases - metabolism; Proteins; Proto-Oncogene Proteins; Rodents; Signal Transduction
• ISSN: 0300-8177; 1573-4919
• DOI: 10.1023/A:1006989232646

We have used a sequential, qualitative biosensor based assay to demonstrate that OA15, a monoclonal antibody which enhances in vivo the activity of bovine growth hormone (bGH) does not disrupt the interaction between bGH and its cognate receptor (as represented by recombinant bovine GH binding protein -rbGHBP). We have confirmed this using a classical cell-based radio-receptor assay with the GH-responsive mouse pre-adipocyte cell line 3T3-F442A. The fact that OA 15 binding to bGH still allows hormone to interact with its receptor, allows us to test the hypothesis that there is any amplification of signalling events following hormone-MAb treatment of 3T3-F442A cells. We have used as a reporter of GH activity the rapid stimulation of JAK-2 tyrosine phosphorylation which is a critical first step in GH signalling events. We demonstrate that binding of rbGH by OA15 attenuates hormone stimulation of JAK-2 tyrosine phosphorylation. We conclude that although OA15 does not disrupt GH-GH receptor (GHR) interactions it does interfere with subsequent GH activity at the molecular and cellular level. We further speculate therefore that the biological enhancing activity of this antibody is most likely due to an in vivo effect as presentation of antibody-hormone complexes to a GH-target cell inhibits hormone activity.